Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Bruce J. Gould"'
Autor:
Terry S. Langbaum, Elizabeth A. Nardi, Bruce J Gould, James McCanney, C. Lyn Fitzgerald, Katy Winckworth-Prejsnar, Robert W. Carlson, F. Marc Stewart
Publikováno v:
Journal of the National Comprehensive Cancer Network. 15:1460-1464
The inability to obtain the right high-quality cancer care in a timely and safe manner can have devastating results for patients. As cancer care becomes inundated with cutting edge and novel treatments, such as personalized medicine, oral chemotherap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9445d8c661bc193c8bddaac7ac5ec404
https://doi.org/10.6004/jnccn.2017.7049
https://doi.org/10.6004/jnccn.2017.7049
Autor:
Bruce J, Gould
Publikováno v:
Oncology (Williston Park, N.Y.). 25(14)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::73247a0d9fc3379eb144968f325e6c52
https://pubmed.ncbi.nlm.nih.gov/22329180
https://pubmed.ncbi.nlm.nih.gov/22329180
Autor:
Bruce J, Gould
Publikováno v:
Journal of Oncology Practice. 10:154-154
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54c4e78e90ad8b229a47917e36298914
https://doi.org/10.1200/jop.2013.001306
https://doi.org/10.1200/jop.2013.001306
Autor:
Douglas Anthony, Louis M. Weiner, Arthur E. Frankel, Bruce J. Gould, Michael J. Borowitz, Eric S. Groves, Peter W. Carter
Publikováno v:
JNCI Journal of the National Cancer Institute. 81:775-781
260F9 Monoclonal antibody-recombinant ricin A chain, an immunotoxin reactive with approximately 50% of breast carcinomas, was given by continuous iv infusion at a dose of 50 micrograms/kg per day or 100 micrograms/kg per day. Five patients with refra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28322c64966ee065bbff037e4c2079e2
https://doi.org/10.1093/jnci/81.10.775
https://doi.org/10.1093/jnci/81.10.775
Publikováno v:
Breast Cancer Immunodiagnosis and Immunotherapy ISBN: 9781475712988
Immunotoxins(IT) are biologically derived compounds that are under development as anti-neoplastic agents(1`. An immunotoxin consists of a carrier protein that guides a covalently linked toxin to a tumor cell. Monoclonal antibodies which have specific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::023009d3424aa9b0994a5c6a95f40039
https://doi.org/10.1007/978-1-4757-1296-4_22
https://doi.org/10.1007/978-1-4757-1296-4_22
